Effective lens position and pseudophakic refraction prediction error at 10½ years of age in the Infant Aphakia Treatment Study.


Journal

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
ISSN: 1528-3933
Titre abrégé: J AAPOS
Pays: United States
ID NLM: 9710011

Informations de publication

Date de publication:
08 2022
Historique:
received: 20 12 2021
revised: 20 02 2022
accepted: 03 04 2022
pubmed: 23 7 2022
medline: 19 10 2022
entrez: 22 7 2022
Statut: ppublish

Résumé

The refraction prediction error (PE) for infants with intraocular lens (IOL) implantation is large, possibly related to an effective lens position (ELP) that is different than in adult eyes. If these eyes still have nonadult ELPs as they age, this could result in persistently large PE. We aimed to determine whether ELP or biometry at age 10½ years correlated with PE in children enrolled in the Infant Aphakia Treatment Study (IATS). We compared the measured refraction of eyes randomized to primary IOL implantation to the "predicted refraction" calculated by the Holladay 1 formula, based on biometry at age 10½ years. Eyes with incomplete data or IOL exchange were excluded. The PE (predicted - measured refraction) and absolute PE were calculated. Measured anterior chamber depth (ACD) was used to assess the effect of ELP on PE. Multiple regression analysis was performed on absolute PE versus axial length, corneal power, rate of refractive growth, refractive error, and best-corrected visual acuity. Forty-three eyes were included. The PE was 0.63 ± 1.68 D; median absolute PE, 0.85 D (IQR, 1.83 D). The median absolute PE was greater when the measured ACD was used to calculate predicted refraction instead of the standard A-constant (1.88 D [IQR, 1.72] D vs 0.85 D [IQR, 1.83], resp. [P = 0.03]). Absolute PE was not significantly correlated with any other parameter. Variations in ELP did not contribute significantly to PE 10 years after infant cataract surgery.

Sections du résumé

BACKGROUND
The refraction prediction error (PE) for infants with intraocular lens (IOL) implantation is large, possibly related to an effective lens position (ELP) that is different than in adult eyes. If these eyes still have nonadult ELPs as they age, this could result in persistently large PE. We aimed to determine whether ELP or biometry at age 10½ years correlated with PE in children enrolled in the Infant Aphakia Treatment Study (IATS).
METHODS
We compared the measured refraction of eyes randomized to primary IOL implantation to the "predicted refraction" calculated by the Holladay 1 formula, based on biometry at age 10½ years. Eyes with incomplete data or IOL exchange were excluded. The PE (predicted - measured refraction) and absolute PE were calculated. Measured anterior chamber depth (ACD) was used to assess the effect of ELP on PE. Multiple regression analysis was performed on absolute PE versus axial length, corneal power, rate of refractive growth, refractive error, and best-corrected visual acuity.
RESULTS
Forty-three eyes were included. The PE was 0.63 ± 1.68 D; median absolute PE, 0.85 D (IQR, 1.83 D). The median absolute PE was greater when the measured ACD was used to calculate predicted refraction instead of the standard A-constant (1.88 D [IQR, 1.72] D vs 0.85 D [IQR, 1.83], resp. [P = 0.03]). Absolute PE was not significantly correlated with any other parameter.
CONCLUSIONS
Variations in ELP did not contribute significantly to PE 10 years after infant cataract surgery.

Identifiants

pubmed: 35868622
pii: S1091-8531(22)00139-2
doi: 10.1016/j.jaapos.2022.04.010
pmc: PMC9588666
mid: NIHMS1824999
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

172.e1-172.e5

Subventions

Organisme : NEI NIH HHS
ID : UG1 EY013287
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY026877
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY013272
Pays : United States
Organisme : NEI NIH HHS
ID : U10 EY013287
Pays : United States
Organisme : NEI NIH HHS
ID : UG1 EY025553
Pays : United States
Organisme : NEI NIH HHS
ID : UG1 EY013272
Pays : United States

Informations de copyright

Copyright © 2022 American Association for Pediatric Ophthalmology and Strabismus. All rights reserved.

Références

J Cataract Refract Surg. 2021 Apr 1;47(4):512-515
pubmed: 33181631
J Cataract Refract Surg. 2011 Nov;37(11):2018-27
pubmed: 22018365
Dev Ophthalmol. 2016;57:29-39
pubmed: 27043390
J Cataract Refract Surg. 2011 Mar;37(3):501-5
pubmed: 21333874
J Cataract Refract Surg. 2008 Mar;34(3):368-76
pubmed: 18299059
Arch Ophthalmol. 2012 Mar;130(3):293-9
pubmed: 22411658
Am J Ophthalmol. 2013 Dec;156(6):1252-1260.e2
pubmed: 24011524
J Cataract Refract Surg. 1988 Jan;14(1):17-24
pubmed: 3339543
Ophthalmology. 2010 Aug;117(8):1493-9
pubmed: 20466430
J Cataract Refract Surg. 1990 May;16(3):305-11
pubmed: 2355315
Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2325-33
pubmed: 1607244
J Cataract Refract Surg. 1997 Nov;23(9):1356-70
pubmed: 9423908
Am J Ophthalmol. 2004 Jun;137(6):1101-4
pubmed: 15183796
Arch Ophthalmol. 2010 Jan;128(1):21-7
pubmed: 20065212
Am J Ophthalmol. 2020 Aug;216:147-155
pubmed: 32304705
J Ophthalmol. 2019 May 14;2019:2796126
pubmed: 31218083
Eye (Lond). 2016 Sep;30(9):1242-50
pubmed: 27494083

Auteurs

Deborah K VanderVeen (DK)

Department of Ophthalmology, Harvard Medical School, Boston, Massachsuetts. Electronic address: deborah.vanderveen@childrens.harvard.edu.

Thaddeus S McClatchey (TS)

Department of Ophthalmology, Naval Medical Center, San Diego, California; School of Medicine, California University of Science and Medicine, San Bernardino, California.

Scott K McClatchey (SK)

Department of Ophthalmology, Naval Medical Center, San Diego, California; Uniformed Services University of Health Sciences, Bethesda, Maryland.

Azhar Nizam (A)

Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, Georgia.

Scott R Lambert (SR)

Department of Ophthalmology, School of Medicine, Stanford University, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH